Maria Teresa Frejo

Maria Teresa Frejo

Auto-generated profile, based on publicly available information

Maria Teresa Frejo

Department of Toxicology and Pharmacology, Veterinary School, Complutense University of Madrid, 28040 Madrid, Spain

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2015 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
JSJavier Del Pino Sans
Javier Del Pino Sans
GZGabriela Zeballos
Gabriela Zeballos
MBMª José Anadón Baselga
Mª José Anadón Baselga
PMPaula Moyano
Paula Moyano
MDMaría Jesús Díaz
María Jesús Díaz
MFMaría Teresa Frejo
María Teresa Frejo

1 October 2001 in Research in Veterinary Science
Verified
Journal Article
Closed access
AAArturo Anadón
Arturo Anadón
MMM.R Martı́nez-Larrañaga
M.R Martı́nez-Larrañaga
JIJ Iturbe
J Iturbe
MMM.A Martı́nez
M.A Martı́nez
MDM.J Dı́az
M.J Dı́az
MMM Martı́nez
M Martı́nez

1 July 2002 in American Journal of Veterinary Research
Verified
Journal Article
Closed access
AAArturo Anadón
Arturo Anadón
MMMaría R. Martínez-Larrañaga
María R. Martínez-Larrañaga
MDMaría J. Díaz
María J. Díaz
MMMaría A. Martínez
María A. Martínez
MFMaría T. Frejo
María T. Frejo
VCVictor J. Castellano
Victor J. Castellano
Objectives —To determine pharmacokinetic characteristics of marbofloxacin after a single IV and oral administration and tissue residues after serial daily oral administration in chickens. Animals —40 healthy broiler chickens. Procedure —Two groups of chickens (groups A and B; 8 chickens/group) were administered a single IV and oral administration of marbofloxacin (2 mg/kg). Chickens of group C (n = 24) were given serial daily doses of marbofloxacin (2 mg/kg, PO, q 24 h for 3 days). Plasma (groups A and B) and tissue concentrations (group C) of marbofloxacin and its major metabolite N -desmethyl-marbofloxacin were determined by use of high-performance liquid chromatography. Residues of marbofloxacin and N -desmethyl-marbofloxacin were measured in target tissues. Results —Elimination half-life and mean residence time of marbofloxacin in plasma were 5.26 and 4.36 hours after IV administration and 8.69 and 8.55 hours after oral administration, respectively. Maximal plasma concentration was 1.05 µg/ml, and interval from oral administration until maximum concentration was 1.48 hours. Oral bioavailability of marbofloxacin was 56.82%. High concentrations of marbofloxacin and N -desmethyl- marbofloxacin were found in the kidneys, liver, muscles, and skin plus fat 24 hours after the final dose of marbofloxacin; however, marbofloxacin and N -desmethyl-marbofloxacin were detected in only hepatic (27.6 and 98.7 µg/kg, respectively) and renal (39.7 and 69.1 µg/kg, respectively) tissues 72 hours after termination of marbofloxacin treatment. Conclusions and Clinical Relevance —Analysis of pharmacokinetic data obtained in this study reveals that a minimal therapeutic dose of 2 mg/kg, PO, every 24 hours should be appropriate for control of most infections in chickens. ( Am J Vet Res 2002; 63:927–933)

1 November 2014 in Toxicology
Verified
Journal Article
Closed access
JSJavier Del Pino Sans
Javier Del Pino Sans
GZGarbriela Zeballos
Garbriela Zeballos
MBMª José Anadón Baselga
Mª José Anadón Baselga
MCMiguel Andrés Capo
Miguel Andrés Capo
MDMaría Jesús Díaz
María Jesús Díaz
MFMaría Teresa Frejo
María Teresa Frejo


14 May 2015 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
JSJavier Del Pino Sans
Javier Del Pino Sans
PMPaula Viviana Moyano-Cires
Paula Viviana Moyano-Cires
MBMª José Anadón Baselga
Mª José Anadón Baselga
MDMaría Jesús Díaz
María Jesús Díaz
MLMargarita Lobo
Margarita Lobo
MFMaría Teresa Frejo
María Teresa Frejo